Surrozen (SRZN) Assets Average (2020 - 2026)
Surrozen (SRZN) recorded quarterly Assets Average of $109.7 million in Q1 2026, up 13.83% quarter-over-quarter from $96.4 million in Q4 2025, and up 34.38% on a YoY basis from $81.6 million in Q1 2025.
Surrozen (SRZN) Assets Average (2020 - 2026) Analysis & Trends
Surrozen's Assets Average history runs 7 years deep, the most recent figure standing at $109.7 million for Q1 2026.
- In Q1 2026, Assets Average rose 34.38% year-over-year to $109.7 million; the TTM figure through Mar 2026 stood at $109.7 million (up 34.38% YoY), while the FY2025 annual figure was $73.6 million, up 55.68% from the prior year.
- Assets Average was $109.7 million for Q1 2026 at Surrozen, up from $96.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $127.4 million in Q1 2022 to a low of $40.9 million in Q2 2024.
- Historically, Assets Average has averaged $79.9 million across 5 years, with a median of $81.8 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Assets Average slumped 49.4% in 2024, then soared 165.97% in 2025.
- A 5-year view of Assets Average shows it stood at $90.4 million in 2022, then tumbled by 44.68% to $50.0 million in 2023, then declined by 3.59% to $48.2 million in 2024, then surged by 99.84% to $96.4 million in 2025, then climbed by 13.83% to $109.7 million in 2026.
- The last three Assets Average figures came in at $109.7 million (Q1 2026), $96.4 million (Q4 2025), and $98.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 660.38 Mn |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - | 109.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.72 Mn |
| Dec 31, 2025 | 96.39 Mn |
| Sep 30, 2025 | 98.37 Mn |
| Jun 30, 2025 | 108.76 Mn |
| Mar 31, 2025 | 81.65 Mn |
| Dec 31, 2024 | 48.23 Mn |
| Sep 30, 2024 | 46.53 Mn |
| Jun 30, 2024 | 40.89 Mn |
| Mar 31, 2024 | 41.40 Mn |
| Dec 31, 2023 | 50.03 Mn |
| Sep 30, 2023 | 58.99 Mn |
| Jun 30, 2023 | 69.10 Mn |
| Mar 31, 2023 | 81.82 Mn |
| Dec 31, 2022 | 90.43 Mn |
| Sep 30, 2022 | 97.78 Mn |
| Jun 30, 2022 | 110.89 Mn |
| Mar 31, 2022 | 127.41 Mn |
| Dec 31, 2021 | 143.91 Mn |
| Sep 30, 2021 | 121.79 Mn |
| Jun 30, 2021 | 93.19 Mn |